Real-time enrollment status for this ovarian high grade serous adenocarcinoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 7:33 AM UTC
| NCT Number | NCT05998135 |
| Recruiting Status | Recruiting |
| Condition | Ovarian High Grade Serous Adenocarcinoma |
| Phase | PHASE2 |
| Target Enrollment | 28 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Emory University |
| Last Updated on CT.gov | September 11, 2025 (Sep 11, 2025) |
As of July 17, 2026: Clinical trial NCT05998135 is currently recruiting participants. This phase2 study for ovarian high grade serous adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Emory University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05998135 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05998135 was last updated Sep 11, 2025 (September 11, 2025). HelloStudys verifies this status automatically.